Park et al. analysed the characteristics of HNSCC in TCGA and identified nine candidate CAR-T antigens among previously reported CAR-T antigens, ultimately selecting the antigen CD70 to investigate the function of its CAR-T cells in the specific recognition and killing of HNSCC in vitro. This evidence concerns the gene CD70 and head and neck squamous cell carcinoma.